Amgen Inc. (AMGN)
NASDAQ: AMGN · Real-Time Price · USD
364.65
-11.17 (-2.97%)
At close: Feb 10, 2026, 4:00 PM EST
365.03
+0.38 (0.10%)
After-hours: Feb 10, 2026, 7:52 PM EST

Amgen Revenue

In the year 2025, Amgen had annual revenue of $36.75B with 9.95% growth. Amgen had revenue of $9.87B in the quarter ending December 31, 2025, with 8.58% growth.

Revenue (ttm)
$36.75B
Revenue Growth
+9.95%
P/S Ratio
5.34
Revenue / Employee
$1,312,536
Employees
28,000
Market Cap
196.36B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202536.75B3.33B9.95%
Dec 31, 202433.42B5.23B18.57%
Dec 31, 202328.19B1.87B7.09%
Dec 31, 202226.32B344.00M1.32%
Dec 31, 202125.98B555.00M2.18%
Dec 31, 202025.42B2.06B8.83%
Dec 31, 201923.36B-385.00M-1.62%
Dec 31, 201823.75B898.00M3.93%
Dec 31, 201722.85B-142.00M-0.62%
Dec 31, 201622.99B1.33B6.14%
Dec 31, 201521.66B1.60B7.97%
Dec 31, 201420.06B1.39B7.43%
Dec 31, 201318.68B1.41B8.17%
Dec 31, 201217.27B1.68B10.80%
Dec 31, 201115.58B529.00M3.51%
Dec 31, 201015.05B411.00M2.81%
Dec 31, 200914.64B-361.00M-2.41%
Dec 31, 200815.00B232.00M1.57%
Dec 31, 200714.77B503.00M3.53%
Dec 31, 200614.27B1.84B14.79%
Dec 31, 200512.43B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Johnson & Johnson94.19B
Merck & Co.65.01B
Pfizer62.58B
AbbVie61.16B
AstraZeneca58.13B
Novartis AG56.67B
Sanofi54.85B
Novo Nordisk48.59B
Revenue Rankings